1. Brunel University Research Archive
  2. College of Health, Medicine and Life Sciences
  3. Dept of Life Sciences
  4. Dept of Life Sciences Research Papers
Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/26189
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStaffaroni, AM-
dc.contributor.authorQuintana, M-
dc.contributor.authorWendelberger, B-
dc.contributor.authorHeuer, HW-
dc.contributor.authorRussell, LL-
dc.contributor.authorCobigo, Y-
dc.contributor.authorWolf, A-
dc.contributor.authorGoh, S-YM-
dc.contributor.authorPetrucelli, L-
dc.contributor.authorGendron, TF-
dc.contributor.authorHeller, C-
dc.contributor.authorRamanan, VK-
dc.contributor.authorRamos, EM-
dc.contributor.authorRao, M-
dc.contributor.authorRascovsky, K-
dc.contributor.authorRankin, KP-
dc.contributor.authorRoberson, ED-
dc.contributor.authorSavica, R-
dc.contributor.authorTartaglia, MC-
dc.contributor.authorWeintraub, S-
dc.contributor.authorWong, B-
dc.contributor.authorCash, DM-
dc.contributor.authorBouzigues, A-
dc.contributor.authorSwift, IJ-
dc.contributor.authorPeakman, G-
dc.contributor.authorBocchetta, M-
dc.contributor.authorTodd, EG-
dc.contributor.authorConvery, RS-
dc.contributor.authorRowe, JB-
dc.contributor.authorBorroni, B-
dc.contributor.authorGalimberti, D-
dc.contributor.authorTiraboschi, P-
dc.contributor.authorMasellis, M-
dc.contributor.authorFinger, E-
dc.contributor.authorvan Swieten, JC-
dc.contributor.authorSeelaar, H-
dc.contributor.authorJiskoot, LC-
dc.contributor.authorSorbi, S-
dc.contributor.authorButler, CR-
dc.contributor.authorGraff, C-
dc.contributor.authorGerhard, A-
dc.contributor.authorLangheinrich, T-
dc.contributor.authorLaforce, R-
dc.contributor.authorSanchez-Valle, R-
dc.contributor.authorde Mendonça, A-
dc.contributor.authorMoreno, F-
dc.contributor.authorSynofzik, M-
dc.contributor.authorVandenberghe, R-
dc.contributor.authorDucharme, S-
dc.contributor.authorLe Ber, I-
dc.contributor.authorLevin, J-
dc.contributor.authorDanek, A-
dc.contributor.authorOtto, M-
dc.contributor.authorPasquier, F-
dc.contributor.authorSantana, I-
dc.contributor.authorKornak, J-
dc.contributor.authorBoeve, BF-
dc.contributor.authorRosen, HJ-
dc.contributor.authorRohrer, JD-
dc.contributor.authorBoxer, AL-
dc.contributor.authorFrontotemporal Dementia Prevention Initiative (FPI) Investigators-
dc.contributor.authorClark, AL-
dc.contributor.authorTaylor, JC-
dc.contributor.authorWise, A-
dc.contributor.authorOng, E-
dc.contributor.authorForsberg, L-
dc.contributor.authorBrushaber, D-
dc.contributor.authorRojas, JC-
dc.contributor.authorVandeVrede, L-
dc.contributor.authorLjubenkov, P-
dc.contributor.authorKramer, J-
dc.contributor.authorCasaletto, KB-
dc.contributor.authorAppleby, B-
dc.contributor.authorBordelon, Y-
dc.contributor.authorBotha, H-
dc.contributor.authorDickerson, BC-
dc.contributor.authorDomoto-Reilly, K-
dc.contributor.authorFields, JA-
dc.contributor.authorForoud, T-
dc.contributor.authorGavrilova, R-
dc.contributor.authorGeschwind, D-
dc.contributor.authorGhoshal, N-
dc.contributor.authorGoldman, J-
dc.contributor.authorGraff-Radford, J-
dc.contributor.authorGraff-Radford, N-
dc.contributor.authorGrossman, M-
dc.contributor.authorHall, MGH-
dc.contributor.authorHsiung, G-Y-
dc.contributor.authorHuey, ED-
dc.contributor.authorIrwin, D-
dc.contributor.authorJones, DT-
dc.contributor.authorKantarci, K-
dc.contributor.authorKaufer, D-
dc.contributor.authorKnopman, D-
dc.contributor.authorKremers, W-
dc.contributor.authorLago, AL-
dc.contributor.authorLapid, MI-
dc.contributor.authorLitvan, I-
dc.contributor.authorLucente, D-
dc.contributor.authorMackenzie, IR-
dc.contributor.authorMendez, MF-
dc.contributor.authorMester, C-
dc.contributor.authorMiller, BL-
dc.contributor.authorOnyike, CU-
dc.contributor.authorRademakers, R-
dc.date.accessioned2023-03-24T10:41:24Z-
dc.date.available2023-03-24T10:41:24Z-
dc.date.issued2022-09-22-
dc.identifierORCID iD: Martina Bocchetta https://orcid.org/0000-0003-1814-5024-
dc.identifier.citationStaffaroni, A.M. et al. (2022) 'Temporal order of clinical and biomarker changes in familial frontotemporal dementia', Nature Medicine, 28 (10), pp. 2194 - 2206. doi: 10.1038/s41591-022-01942-9.en_US
dc.identifier.issn1078-8956-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/26189-
dc.descriptionData availability: The datasets analyzed for the current study reflect collaborative efforts of two research consortia: ALLFTD and GENFI. Each consortium provides clinical data access based on established policies for data use: processes for request are available for review at allftd.org/data for ALLFTD data and by emailing genfi@ucl.ac.uk. Certain data elements from both consortia (for example raw MRI images) may be restricted due to the potential for identifiability in the context of the sensitive nature of the genetic data. The deidentified combined dataset will be available for request through the FTD Prevention Initiative in 2023 (https://www.thefpi.org/).en_US
dc.descriptionCode availability: Custom R code is available at https://doi.org/10.5281/zenodo.6687486.-
dc.description.abstractCopyright © The Author(s). Unlike familial Alzheimer’s disease, we have been unable to accurately predict symptom onset in presymptomatic familial frontotemporal dementia (f-FTD) mutation carriers, which is a major hurdle to designing disease prevention trials. We developed multimodal models for f-FTD disease progression and estimated clinical trial sample sizes in C9orf72, GRN and MAPT mutation carriers. Models included longitudinal clinical and neuropsychological scores, regional brain volumes and plasma neurofilament light chain (NfL) in 796 carriers and 412 noncarrier controls. We found that the temporal ordering of clinical and biomarker progression differed by genotype. In prevention-trial simulations using model-based patient selection, atrophy and NfL were the best endpoints, whereas clinical measures were potential endpoints in early symptomatic trials. f-FTD prevention trials are feasible but will likely require global recruitment efforts. These disease progression models will facilitate the planning of f-FTD clinical trials, including the selection of optimal endpoints and enrollment criteria to maximize power to detect treatment effects.en_US
dc.description.sponsorshipData collection and dissemination of the data presented in this paper were supported by the ALLFTD Consortium (U19: AG063911, funded by the National Institute on Aging and the National Institute of Neurological Diseases and Stroke) and the former ARTFL and LEFFTDS Consortia (ARTFL: U54 NS092089, funded by the National Institute of Neurological Diseases and Stroke and National Center for Advancing Translational Sciences; LEFFTDS: U01 AG045390, funded by the National Institute on Aging and the National Institute of Neurological Diseases and Stroke). The manuscript was reviewed by the ALLFTD Executive Committee for scientific content. The authors acknowledge the invaluable contributions of the study participants and families as well as the assistance of the support staffs at each of the participating sites. This work is also supported by the Association for Frontotemporal Degeneration (including the FTD Biomarkers Initiative), the Bluefield Project to Cure FTD, Larry L. Hillblom Foundation (2018-A-025-FEL (A.M.S.)), the National Institutes of Health (AG038791 (A.L.B.), AG032306 (H.J.R.), AG016976 (W.K.), AG062677 (Ron C. Peterson), AG019724 (B.L.M.), AG058233 (Suzee E. Lee), AG072122 (Walter Kukull), P30 AG062422 (B.L.M.), K12 HD001459 (N.G.), K23AG061253 (A.M.S.), AG062422 (RCP), K24AG045333 (H.J.R.)) and the Rainwater Charitable Foundation. Samples from the National Centralized Repository for Alzheimer Disease and Related Dementias (NCRAD), which receives government support under a cooperative agreement grant (U24 AG021886 (T.F.)) awarded by the National Institute on Aging (NIA), were used in this study. This work was also supported by Medical Research Council UK GENFI grant MR/M023664/1 (J.D.R.), the Bluefield Project, the National Institute for Health Research including awards to Cambridge and UCL Biomedical Research Centres and a JPND GENFI-PROX grant (2019–02248). Several authors of this publication are members of the European Reference Network for Rare Neurologic Diseases, project 739510. J.D.R. and L.L.R. are also supported by the National Institute for Health and Care Research (NIHR) UCL/H Biomedical Research Centre, the Leonard Wolfson Experimental Neurology Centre Clinical Research Facility and the UK Dementia Research Institute, which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK. J.D.R. is also supported by the Miriam Marks Brain Research UK Senior Fellowship and has received funding from an MRC Clinician Scientist Fellowship (MR/M008525/1) and the NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH). M.B. is supported by a Fellowship award from the Alzheimer’s Society, UK (AS-JF-19a-004-517). RC and C.G. are supported by a Frontotemporal Dementia Research Studentships in Memory of David Blechner funded through The National Brain Appeal (RCN 290173). J.B.R. is supported by NIHR Cambridge Biomedical Research Centre (BRC-1215-20014; the views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care), the Wellcome Trust (220258), the Cambridge Centre for Parkinson-plus and the Medical Research Council (SUAG/092 G116768); I.L.B. is supported by ANR-PRTS PREV-DemAls, PHRC PREDICT-PGRN, and several authors of this publication are members of the European Reference Network for Rare Neurological Diseases (project 739510). J.L. is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy – ID 390857198). R.S.-V. was funded at the Hospital Clinic de Barcelona by Instituto de Salud Carlos III, Spain (grant code PI20/00448 to RSV) and Fundació Marató TV3, Spain (grant code 20143810 to R.S.-V.). M.M. was, in part, funded by the UK Medical Research Council, the Italian Ministry of Health and the Canadian Institutes of Health Research as part of a Centres of Excellence in Neurodegeneration grant, by Canadian Institutes of Health Research operating grants (MOP- 371851 and PJT-175242) and by funding from the Weston Brain Institute. R.L. is supported by the Canadian Institutes of Health Research and the Chaire de Recherche sur les Aphasies Primaires Progressives Fondation Famille Lemaire. C.G. is supported by the Swedish Frontotemporal Dementia Initiative Schörling Foundation, Swedish Research Council, JPND Prefrontals, 2015–02926,2018–02754, Swedish Alzheimer Foundation, Swedish Brain Foundation, Karolinska Institutet Doctoral Funding, KI Strat-Neuro, Swedish Dementia Foundation, and Stockholm County Council ALF/Region Stockholm. J.L. is supported by Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (German Research Foundation, EXC 2145 Synergy 390857198). The Dementia Research Centre is supported by Alzheimer’s Research UK, Alzheimer’s Society, Brain Research UK, and The Wolfson Foundation. This work was supported by the National Institute for Health Research UCL/H Biomedical Research Centre, the Leonard Wolfson Experimental Neurology Centre Clinical Research Facility and the UK Dementia Research Institute, which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK.en_US
dc.format.extent2194 - 2206-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.rightsCopyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1038/s41591-022-01942-9. Rights and permissions: Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. (see: https://www.springernature.com/gp/open-research/policies/journal-policies).-
dc.rights.urihttps://www.springernature.com/gp/open-research/policies/journal-policies-
dc.subjectbiomarkersen_US
dc.subjectdementiaen_US
dc.titleTemporal order of clinical and biomarker changes in familial frontotemporal dementiaen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1038/s41591-022-01942-9-
dc.relation.isPartOfNature medicine-
pubs.issue10-
pubs.publication-statusPublished-
pubs.volume28-
dc.identifier.eissn1546-170X-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1038/s41591-022-01942-9. Rights and permissions: Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. (see: https://www.springernature.com/gp/open-research/policies/journal-policies).14.74 MBAdobe PDFView/Open
Show simple item record


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.